Clinical Trials

NCT06640478 | ACTIVE_NOT_RECRUITING | NA

20 participants

A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-11-20

Completion:

2026-10-30

Conditions

• Type 1 Diabetes

Interventions

• OTHER
• DIETARY_SUPPLEMENT

No Results Yet

NCT06635876 | COMPLETED | NA

72 participants

Caregivers Preparing for Their Own Health Care Emergency

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-07-18

Completion:

2026-06-11

Conditions

• Dementia
• Caregiver Burden

Interventions

• BEHAVIORAL

No Results Yet

NCT06635785 | RECRUITING | PHASE1/PHASE2

387 participants

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-03-26

Completion:

2027-06-30

Conditions

• Advanced Solid Tumor

Interventions

• DRUG

No Results Yet

NCT06635447 | ACTIVE_NOT_RECRUITING | PHASE3

293 participants

Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-09-26

Completion:

2026-10-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT06632236 | ACTIVE_NOT_RECRUITING | PHASE1

12 participants

5G-EMERALD: Amivantamab in Malignant Brain Tumours

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-10-09

Completion:

2027-07-01

Conditions

• Malignant Primary Gliomas
• Glioblastoma Multiform (Grade IV Astrocytoma)
• Diffuse Hemispheric Glioma, H3 G34-Mutant
• Glioblastoma Multiforme (GBM)

Interventions

• DRUG

No Results Yet

NCT06628011 | RECRUITING | NA

40 participants

Digital Follow-up of Aerobic Interval Training in Outpatients With Mental Disorders

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-01-01

Completion:

2030-01-01

Conditions

• Severe Mental Disorder

Interventions

• OTHER

No Results Yet

NCT06626789 | RECRUITING | PHASE1/PHASE2

164 participants

Brain Signal Training to Enhance Affect Down-regulation

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-04-23

Completion:

2027-12-31

Conditions

• Borderline Personality Disorder

Interventions

• BIOLOGICAL
• BEHAVIORAL

No Results Yet

NCT06616766 | RECRUITING | PHASE1/PHASE2

201 participants

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-10-02

Completion:

2028-03-15

Conditions

• NSCLC (Non-small Cell Lung Cancer)
• Solid Tumor

Interventions

• DRUG

No Results Yet

NCT06605378 | RECRUITING

60 participants

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-17

Start Date:

2024-11-18

Completion:

2026-12-31

Conditions

• Chronic Granulomatous Disease (CGD)

No Results Yet

NCT06588686 | ACTIVE_NOT_RECRUITING | PHASE2

378 participants

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-12-09

Completion:

2027-05-31

Conditions

• Idiopathic Pulmonary Fibrosis (IPF)

Interventions

• DRUG

No Results Yet

NCT06585410 | RECRUITING | PHASE3

369 participants

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-01-02

Completion:

2030-05-03

Conditions

• Cutaneous Squamous Cell Carcinoma (CSCC)

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT06577766 | ACTIVE_NOT_RECRUITING | PHASE1

63 participants

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-09-03

Completion:

2027-10-11

Conditions

• Obesity
• Overweight

Interventions

• DRUG

No Results Yet

NCT06574152 | RECRUITING | NA

90 participants

Effect of Photobiomodulation on Pain and Healing of the Vertical Releasing Incision After Endodontic Microsurgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-08-20

Completion:

2028-05-04

Conditions

• Apical Periodontitis
• Endodontically Treated Teeth
• Endodontic Disease
• Apical Cyst
• Apical Granuloma
• Periradicular Disease
• Previous Endodontic Treatment

Interventions

• DEVICE

No Results Yet

NCT06570655 | COMPLETED | PHASE1

12 participants

The Study of Pharmacokinetics and Pharmacodynamics of Huperzine A Injection in Healthy Chinese Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-05-16

Completion:

2024-06-20

Conditions

• Healthy Subjects

Interventions

• DRUG

No Results Yet

NCT06569082 | RECRUITING | NA

21 participants

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-10-31

Completion:

2034-08-31

Conditions

• Graft Failure
• Poor Graft Function

Interventions

• DEVICE
• PROCEDURE

No Results Yet

NCT06562270 | RECRUITING

1500 participants

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-17

Start Date:

2024-03-07

Completion:

2099-12-31

Conditions

• Alopecia Areata

No Results Yet

NCT06561386 | RECRUITING | PHASE3

1000 participants

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-10-07

Completion:

2030-07-30

Conditions

• Non-small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT06560021 | ENROLLING_BY_INVITATION | NA

1642 participants

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-01-03

Completion:

2028-12-31

Conditions

• Inflammatory Bowel Diseases
• Crohn Disease
• Ulcerative Colitis

Interventions

• OTHER

No Results Yet

NCT06558201 | ENROLLING_BY_INVITATION | NA

50 participants

Open Label Extension Study of NCT06221852

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-08-28

Completion:

2027-09-30

Conditions

• Bipolar I Disorder
• Schizoaffective Disorder
• Psychosis

Interventions

• OTHER

No Results Yet

NCT06550804 | ACTIVE_NOT_RECRUITING | PHASE3

126 participants

Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-10-01

Completion:

2027-03-31

Conditions

• HIV Infections
• Adherence, Medication

Interventions

• BEHAVIORAL

No Results Yet

NCT06542497 | COMPLETED | PHASE3

569 participants

Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-08-15

Completion:

2025-04-03

Conditions

• Presbyopia

Interventions

• DRUG

Results Available

NCT06535802 | COMPLETED

38 participants

iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-17

Start Date:

2023-11-20

Completion:

2026-06-23

Conditions

• Prostate Carcinoma

Interventions

• OTHER

No Results Yet

NCT06532279 | RECRUITING | PHASE2

98 participants

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-06-23

Completion:

2027-01-01

Conditions

• Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Nasopharyngeal Squamous Cell Carcinoma
• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma
• Stage 0 Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
• Stage 0 Hypopharyngeal Carcinoma AJCC v8
• Stage 0 Nasopharyngeal Carcinoma AJCC v8
• Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8
• Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
• Stage I Hypopharyngeal Carcinoma AJCC v8
• Stage I Laryngeal Cancer AJCC v8
• Stage I Lip and Oral Cavity Cancer AJCC v8
• Stage I Nasopharyngeal Carcinoma AJCC v8
• Stage I Oropharyngeal (p16-Negative) Carcinoma AJCC v8
• Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
• Stage II Hypopharyngeal Carcinoma AJCC v8
• Stage II Laryngeal Cancer AJCC v8
• Stage II Lip and Oral Cavity Cancer AJCC v8
• Stage II Nasopharyngeal Carcinoma AJCC v8
• Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
• Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
• Stage III Hypopharyngeal Carcinoma AJCC v8
• Stage III Laryngeal Cancer AJCC v8
• Stage III Lip and Oral Cavity Cancer AJCC v8
• Stage III Nasopharyngeal Carcinoma AJCC v8
• Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
• Stage IVA Hypopharyngeal Carcinoma AJCC v8
• Stage IVA Laryngeal Cancer AJCC v8
• Stage IVA Lip and Oral Cavity Cancer AJCC v8
• Stage IVA Nasopharyngeal Carcinoma AJCC v8
• Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
• Stage IVB Hypopharyngeal Carcinoma AJCC v8
• Stage IVB Laryngeal Cancer AJCC v8
• Stage IVB Lip and Oral Cavity Cancer AJCC v8
• Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
• Stomatitis

Interventions

• OTHER
• PROCEDURE
• DRUG
• RADIATION

No Results Yet

NCT06528301 | RECRUITING | PHASE1

106 participants

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-03-10

Completion:

2029-03-31

Conditions

• Lymphoma, B-Cell
• Lymphoma, Non-Hodgkin (NHL)
• Lymphoma, Large B-Cell, Diffuse (DLBCL)
• Chronic Lymphocytic Leukemia (CLL)

Interventions

• GENETIC
• DRUG

No Results Yet

NCT06527157 | RECRUITING

4500 participants

Investigations of Reproductive Cancers in Women

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-17

Start Date:

2024-07-30

Completion:

2026-10-30

Conditions

• Uterine Cancer

No Results Yet

NCT06525584 | RECRUITING | NA

196 participants

Ketamine Infusion as a Method of Cerebral Protection in Children

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2023-11-05

Completion:

2028-12-30

Conditions

• Brain Injuries

Interventions

• DRUG
• OTHER

No Results Yet

NCT06519422 | RECRUITING | PHASE3

4000 participants

Tranexamic Acid for Anaemia Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2026-08-10

Completion:

2028-08-31

Conditions

• Anaemia

Interventions

• DRUG

No Results Yet

NCT06500481 | RECRUITING | PHASE3

115 participants

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-03-04

Completion:

2028-07-31

Conditions

• Anatomic Stage IV Breast Cancer AJCC v8
• Metastatic Breast Carcinoma
• Metastatic Lung Non-Small Cell Carcinoma
• Metastatic Malignant Neoplasm in the Leptomeninges
• Stage IV Lung Cancer AJCC v8

Interventions

• PROCEDURE
• RADIATION
• OTHER

No Results Yet

NCT06500455 | RECRUITING | PHASE3

269 participants

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-12-12

Completion:

2028-06-30

Conditions

• Anatomic Stage IV Breast Cancer AJCC v8
• Metastatic Breast Carcinoma
• Metastatic Digestive System Carcinoma
• Metastatic Lung Non-Small Cell Carcinoma
• Metastatic Malignant Neoplasm in the Brain
• Metastatic Malignant Solid Neoplasm
• Metastatic Melanoma
• Metastatic Renal Cell Carcinoma
• Stage IV Lung Cancer AJCC v8
• Stage IV Renal Cell Cancer AJCC v8

Interventions

• PROCEDURE
• RADIATION

No Results Yet

NCT06493006 | COMPLETED

367 participants

Promoting Sustainable and Active Mobility Among Employees and Students

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-17

Start Date:

2024-08-01

Completion:

2026-03-30

Conditions

• Mobility on the Way to Work and Health-related Outcomes

No Results Yet

NCT06492616 | RECRUITING | PHASE3

4220 participants

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-09-27

Completion:

2029-08-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT06492486 | RECRUITING | PHASE2

60 participants

Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2026-07-27

Completion:

2028-07-30

Conditions

• Diffuse Glioma
• Glioblastoma
• Adaptive Radiotherapy
• Artificial Intelligence

Interventions

• RADIATION

No Results Yet

NCT06491446 | COMPLETED | PHASE1/PHASE2

141 participants

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-03-27

Completion:

2025-10-17

Conditions

• Human Papillomavirus Infection

Interventions

• DRUG

No Results Yet

NCT06487559 | ACTIVE_NOT_RECRUITING | PHASE1

3 participants

A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-09-11

Completion:

2027-02-28

Conditions

• Hepatocellular Carcinoma (HCC)

Interventions

• DRUG

No Results Yet

NCT06482268 | RECRUITING | PHASE1

7 participants

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-06-01

Completion:

2027-12-28

Conditions

• PD - Parkinson's Disease

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT06477068 | COMPLETED | NA

361 participants

Effect of a Medication Reminder Mobile Application

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-06-01

Completion:

2026-03-09

Conditions

• Infertility

Interventions

• COMBINATION_PRODUCT

No Results Yet

NCT06458075 | RECRUITING | NA

480 participants

Intervention to Improve Communication and Medication Adherence in Lupus

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-07-01

Completion:

2027-10-31

Conditions

• Systemic Lupus Erythematosus

Interventions

• BEHAVIORAL

No Results Yet

NCT06457152 | COMPLETED | NA

1136 participants

Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-04-04

Completion:

2025-12-04

Conditions

• Heart Failure

Interventions

• OTHER

No Results Yet

NCT06454903 | RECRUITING | NA

75 participants

Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2025-04-02

Completion:

2029-10-31

Conditions

• Opioid-Related Disorders
• Psychosocial Functioning
• Quality of Life

Interventions

• BEHAVIORAL

No Results Yet

NCT06439485 | RECRUITING | PHASE1/PHASE2

25 participants

Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-17

Start Date:

2024-11-19

Completion:

2028-02-22

Conditions

• Advanced Cholangiocarcinoma
• FGFR2 Fusion

Interventions

• DRUG

No Results Yet